[Outcomes of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome without excess blasts]

Zhonghua Xue Ye Xue Za Zhi. 2020 Oct 14;41(10):861-864. doi: 10.3760/cma.j.issn.0253-2727.2020.10.013.

[Article in Chinese]

Authors

Y Yu¹, X H Zhang¹, Y Wang¹, H Chen¹, W Han¹, Y Chen¹, Y Y Zhang¹, Y Y Chen¹, X D Mo¹, H X Fu¹, C H Yan¹, Y Q Sun¹, F R Wang¹, J Z Wang¹, K Y Liu¹, X J Huang¹, L P Xu¹

Affiliation

¹ Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for Hematological Diseases, Beijing 100044, China.

PMID: 33190446
PMCID: PMC7656081
DOI: 10.3760/cma.j.issn.0253-2727.2020.10.013

No abstract available

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Myelodysplastic Syndromes* / therapy
Transplantation Conditioning

Grants and funding

基金项目：国家自然科学基金（81670167、81530046、81621001）